Global Pneumococcal Vaccine Supply, Demand and Key Producers, 2024-2030

Page: 104

Published Date: 09 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Pneumococcal Vaccine market size is expected to reach $ 7972.1 million by 2030, rising at a market growth of 1.1% CAGR during the forecast period (2024-2030).

At present, only MSD, Sanofipasteur and CDIBP can produce PPSV 23, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. As for PCV 13, only Pfizer can supply it. And GSK is the only one manufacturing PCV 10. However, there are some companies working on research of Pneumococcal Vaccine. Pfizer is the leader of this industry with 84% market shares.

North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. The second place is Europe, following North America with sales market share over 18%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.

23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).

This report studies the global Pneumococcal Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Pneumococcal Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pneumococcal Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Pneumococcal Vaccine total production and demand, 2019-2030, (K Doses)
Global Pneumococcal Vaccine total production value, 2019-2030, (USD Million)
Global Pneumococcal Vaccine production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Doses)
Global Pneumococcal Vaccine consumption by region & country, CAGR, 2019-2030 & (K Doses)
U.S. VS China: Pneumococcal Vaccine domestic production, consumption, key domestic manufacturers and share
Global Pneumococcal Vaccine production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Doses)
Global Pneumococcal Vaccine production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Doses)
Global Pneumococcal Vaccine production by End User production, value, CAGR, 2019-2030, (USD Million) & (K Doses).

This reports profiles key players in the global Pneumococcal Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, GSK, MSD, Sanofipasteur and CDIBP, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pneumococcal Vaccine market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Doses) and average price (USD/Dose) by manufacturer, by Type, and by End User. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Pneumococcal Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Pneumococcal Vaccine Market, Segmentation by Type
PPSV 23
PCV 7/13
PCV 10

Global Pneumococcal Vaccine Market, Segmentation by End User
Child
Adult

Companies Profiled:
Pfizer
GSK
MSD
Sanofipasteur
CDIBP

Key Questions Answered
1. How big is the global Pneumococcal Vaccine market?
2. What is the demand of the global Pneumococcal Vaccine market?
3. What is the year over year growth of the global Pneumococcal Vaccine market?
4. What is the production and production value of the global Pneumococcal Vaccine market?
5. Who are the key producers in the global Pneumococcal Vaccine market?

Table of Contents

1 Supply Summary
    1.1 Pneumococcal Vaccine Introduction
    1.2 World Pneumococcal Vaccine Supply & Forecast
        1.2.1 World Pneumococcal Vaccine Production Value (2019 & 2023 & 2030)
        1.2.2 World Pneumococcal Vaccine Production (2019-2030)
        1.2.3 World Pneumococcal Vaccine Pricing Trends (2019-2030)
    1.3 World Pneumococcal Vaccine Production by Region (Based on Production Site)
        1.3.1 World Pneumococcal Vaccine Production Value by Region (2019-2030)
        1.3.2 World Pneumococcal Vaccine Production by Region (2019-2030)
        1.3.3 World Pneumococcal Vaccine Average Price by Region (2019-2030)
        1.3.4 North America Pneumococcal Vaccine Production (2019-2030)
        1.3.5 Europe Pneumococcal Vaccine Production (2019-2030)
        1.3.6 China Pneumococcal Vaccine Production (2019-2030)
        1.3.7 Japan Pneumococcal Vaccine Production (2019-2030)
        1.3.8 India Pneumococcal Vaccine Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Pneumococcal Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Pneumococcal Vaccine Major Market Trends

2 Demand Summary
    2.1 World Pneumococcal Vaccine Demand (2019-2030)
    2.2 World Pneumococcal Vaccine Consumption by Region
        2.2.1 World Pneumococcal Vaccine Consumption by Region (2019-2024)
        2.2.2 World Pneumococcal Vaccine Consumption Forecast by Region (2025-2030)
    2.3 United States Pneumococcal Vaccine Consumption (2019-2030)
    2.4 China Pneumococcal Vaccine Consumption (2019-2030)
    2.5 Europe Pneumococcal Vaccine Consumption (2019-2030)
    2.6 Japan Pneumococcal Vaccine Consumption (2019-2030)
    2.7 South Korea Pneumococcal Vaccine Consumption (2019-2030)
    2.8 ASEAN Pneumococcal Vaccine Consumption (2019-2030)
    2.9 India Pneumococcal Vaccine Consumption (2019-2030)

3 World Pneumococcal Vaccine Manufacturers Competitive Analysis
    3.1 World Pneumococcal Vaccine Production Value by Manufacturer (2019-2024)
    3.2 World Pneumococcal Vaccine Production by Manufacturer (2019-2024)
    3.3 World Pneumococcal Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Pneumococcal Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Pneumococcal Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Pneumococcal Vaccine in 2023
        3.5.3 Global Concentration Ratios (CR8) for Pneumococcal Vaccine in 2023
    3.6 Pneumococcal Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Pneumococcal Vaccine Market: Region Footprint
        3.6.2 Pneumococcal Vaccine Market: Company Product Type Footprint
        3.6.3 Pneumococcal Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Pneumococcal Vaccine Production Value Comparison
        4.1.1 United States VS China: Pneumococcal Vaccine Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Pneumococcal Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Pneumococcal Vaccine Production Comparison
        4.2.1 United States VS China: Pneumococcal Vaccine Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Pneumococcal Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Pneumococcal Vaccine Consumption Comparison
        4.3.1 United States VS China: Pneumococcal Vaccine Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Pneumococcal Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Pneumococcal Vaccine Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Pneumococcal Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Pneumococcal Vaccine Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Pneumococcal Vaccine Production (2019-2024)
    4.5 China Based Pneumococcal Vaccine Manufacturers and Market Share
        4.5.1 China Based Pneumococcal Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Pneumococcal Vaccine Production Value (2019-2024)
        4.5.3 China Based Manufacturers Pneumococcal Vaccine Production (2019-2024)
    4.6 Rest of World Based Pneumococcal Vaccine Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Pneumococcal Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Pneumococcal Vaccine Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Pneumococcal Vaccine Production (2019-2024)

5 Market Analysis by Type
    5.1 World Pneumococcal Vaccine Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 PPSV 23
        5.2.2 PCV 7/13
        5.2.3 PCV 10
    5.3 Market Segment by Type
        5.3.1 World Pneumococcal Vaccine Production by Type (2019-2030)
        5.3.2 World Pneumococcal Vaccine Production Value by Type (2019-2030)
        5.3.3 World Pneumococcal Vaccine Average Price by Type (2019-2030)

6 Market Analysis by End User
    6.1 World Pneumococcal Vaccine Market Size Overview by End User: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by End User
        6.2.1 Child
        6.2.2 Adult
    6.3 Market Segment by End User
        6.3.1 World Pneumococcal Vaccine Production by End User (2019-2030)
        6.3.2 World Pneumococcal Vaccine Production Value by End User (2019-2030)
        6.3.3 World Pneumococcal Vaccine Average Price by End User (2019-2030)

7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Details
        7.1.2 Pfizer Major Business
        7.1.3 Pfizer Pneumococcal Vaccine Product and Services
        7.1.4 Pfizer Pneumococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Pfizer Recent Developments/Updates
        7.1.6 Pfizer Competitive Strengths & Weaknesses
    7.2 GSK
        7.2.1 GSK Details
        7.2.2 GSK Major Business
        7.2.3 GSK Pneumococcal Vaccine Product and Services
        7.2.4 GSK Pneumococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 GSK Recent Developments/Updates
        7.2.6 GSK Competitive Strengths & Weaknesses
    7.3 MSD
        7.3.1 MSD Details
        7.3.2 MSD Major Business
        7.3.3 MSD Pneumococcal Vaccine Product and Services
        7.3.4 MSD Pneumococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 MSD Recent Developments/Updates
        7.3.6 MSD Competitive Strengths & Weaknesses
    7.4 Sanofipasteur
        7.4.1 Sanofipasteur Details
        7.4.2 Sanofipasteur Major Business
        7.4.3 Sanofipasteur Pneumococcal Vaccine Product and Services
        7.4.4 Sanofipasteur Pneumococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Sanofipasteur Recent Developments/Updates
        7.4.6 Sanofipasteur Competitive Strengths & Weaknesses
    7.5 CDIBP
        7.5.1 CDIBP Details
        7.5.2 CDIBP Major Business
        7.5.3 CDIBP Pneumococcal Vaccine Product and Services
        7.5.4 CDIBP Pneumococcal Vaccine Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 CDIBP Recent Developments/Updates
        7.5.6 CDIBP Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Pneumococcal Vaccine Industry Chain
    8.2 Pneumococcal Vaccine Upstream Analysis
        8.2.1 Pneumococcal Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Pneumococcal Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Pneumococcal Vaccine Production Mode
    8.6 Pneumococcal Vaccine Procurement Model
    8.7 Pneumococcal Vaccine Industry Sales Model and Sales Channels
        8.7.1 Pneumococcal Vaccine Sales Model
        8.7.2 Pneumococcal Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Pneumococcal Vaccine Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Pneumococcal Vaccine Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Pneumococcal Vaccine Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Pneumococcal Vaccine Production Value Market Share by Region (2019-2024)
    Table 5. World Pneumococcal Vaccine Production Value Market Share by Region (2025-2030)
    Table 6. World Pneumococcal Vaccine Production by Region (2019-2024) & (K Doses)
    Table 7. World Pneumococcal Vaccine Production by Region (2025-2030) & (K Doses)
    Table 8. World Pneumococcal Vaccine Production Market Share by Region (2019-2024)
    Table 9. World Pneumococcal Vaccine Production Market Share by Region (2025-2030)
    Table 10. World Pneumococcal Vaccine Average Price by Region (2019-2024) & (USD/Dose)
    Table 11. World Pneumococcal Vaccine Average Price by Region (2025-2030) & (USD/Dose)
    Table 12. Pneumococcal Vaccine Major Market Trends
    Table 13. World Pneumococcal Vaccine Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Doses)
    Table 14. World Pneumococcal Vaccine Consumption by Region (2019-2024) & (K Doses)
    Table 15. World Pneumococcal Vaccine Consumption Forecast by Region (2025-2030) & (K Doses)
    Table 16. World Pneumococcal Vaccine Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Pneumococcal Vaccine Producers in 2023
    Table 18. World Pneumococcal Vaccine Production by Manufacturer (2019-2024) & (K Doses)
    Table 19. Production Market Share of Key Pneumococcal Vaccine Producers in 2023
    Table 20. World Pneumococcal Vaccine Average Price by Manufacturer (2019-2024) & (USD/Dose)
    Table 21. Global Pneumococcal Vaccine Company Evaluation Quadrant
    Table 22. World Pneumococcal Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Pneumococcal Vaccine Production Site of Key Manufacturer
    Table 24. Pneumococcal Vaccine Market: Company Product Type Footprint
    Table 25. Pneumococcal Vaccine Market: Company Product Application Footprint
    Table 26. Pneumococcal Vaccine Competitive Factors
    Table 27. Pneumococcal Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Pneumococcal Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Pneumococcal Vaccine Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Pneumococcal Vaccine Production Comparison, (2019 & 2023 & 2030) & (K Doses)
    Table 31. United States VS China Pneumococcal Vaccine Consumption Comparison, (2019 & 2023 & 2030) & (K Doses)
    Table 32. United States Based Pneumococcal Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Pneumococcal Vaccine Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Pneumococcal Vaccine Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Pneumococcal Vaccine Production (2019-2024) & (K Doses)
    Table 36. United States Based Manufacturers Pneumococcal Vaccine Production Market Share (2019-2024)
    Table 37. China Based Pneumococcal Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Pneumococcal Vaccine Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Pneumococcal Vaccine Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Pneumococcal Vaccine Production (2019-2024) & (K Doses)
    Table 41. China Based Manufacturers Pneumococcal Vaccine Production Market Share (2019-2024)
    Table 42. Rest of World Based Pneumococcal Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Pneumococcal Vaccine Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Pneumococcal Vaccine Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Pneumococcal Vaccine Production (2019-2024) & (K Doses)
    Table 46. Rest of World Based Manufacturers Pneumococcal Vaccine Production Market Share (2019-2024)
    Table 47. World Pneumococcal Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Pneumococcal Vaccine Production by Type (2019-2024) & (K Doses)
    Table 49. World Pneumococcal Vaccine Production by Type (2025-2030) & (K Doses)
    Table 50. World Pneumococcal Vaccine Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Pneumococcal Vaccine Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Pneumococcal Vaccine Average Price by Type (2019-2024) & (USD/Dose)
    Table 53. World Pneumococcal Vaccine Average Price by Type (2025-2030) & (USD/Dose)
    Table 54. World Pneumococcal Vaccine Production Value by End User, (USD Million), 2019 & 2023 & 2030
    Table 55. World Pneumococcal Vaccine Production by End User (2019-2024) & (K Doses)
    Table 56. World Pneumococcal Vaccine Production by End User (2025-2030) & (K Doses)
    Table 57. World Pneumococcal Vaccine Production Value by End User (2019-2024) & (USD Million)
    Table 58. World Pneumococcal Vaccine Production Value by End User (2025-2030) & (USD Million)
    Table 59. World Pneumococcal Vaccine Average Price by End User (2019-2024) & (USD/Dose)
    Table 60. World Pneumococcal Vaccine Average Price by End User (2025-2030) & (USD/Dose)
    Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 62. Pfizer Major Business
    Table 63. Pfizer Pneumococcal Vaccine Product and Services
    Table 64. Pfizer Pneumococcal Vaccine Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Pfizer Recent Developments/Updates
    Table 66. Pfizer Competitive Strengths & Weaknesses
    Table 67. GSK Basic Information, Manufacturing Base and Competitors
    Table 68. GSK Major Business
    Table 69. GSK Pneumococcal Vaccine Product and Services
    Table 70. GSK Pneumococcal Vaccine Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. GSK Recent Developments/Updates
    Table 72. GSK Competitive Strengths & Weaknesses
    Table 73. MSD Basic Information, Manufacturing Base and Competitors
    Table 74. MSD Major Business
    Table 75. MSD Pneumococcal Vaccine Product and Services
    Table 76. MSD Pneumococcal Vaccine Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. MSD Recent Developments/Updates
    Table 78. MSD Competitive Strengths & Weaknesses
    Table 79. Sanofipasteur Basic Information, Manufacturing Base and Competitors
    Table 80. Sanofipasteur Major Business
    Table 81. Sanofipasteur Pneumococcal Vaccine Product and Services
    Table 82. Sanofipasteur Pneumococcal Vaccine Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. Sanofipasteur Recent Developments/Updates
    Table 84. CDIBP Basic Information, Manufacturing Base and Competitors
    Table 85. CDIBP Major Business
    Table 86. CDIBP Pneumococcal Vaccine Product and Services
    Table 87. CDIBP Pneumococcal Vaccine Production (K Doses), Price (USD/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 88. Global Key Players of Pneumococcal Vaccine Upstream (Raw Materials)
    Table 89. Pneumococcal Vaccine Typical Customers
    Table 90. Pneumococcal Vaccine Typical Distributors
List of Figure
    Figure 1. Pneumococcal Vaccine Picture
    Figure 2. World Pneumococcal Vaccine Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Pneumococcal Vaccine Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Pneumococcal Vaccine Production (2019-2030) & (K Doses)
    Figure 5. World Pneumococcal Vaccine Average Price (2019-2030) & (USD/Dose)
    Figure 6. World Pneumococcal Vaccine Production Value Market Share by Region (2019-2030)
    Figure 7. World Pneumococcal Vaccine Production Market Share by Region (2019-2030)
    Figure 8. North America Pneumococcal Vaccine Production (2019-2030) & (K Doses)
    Figure 9. Europe Pneumococcal Vaccine Production (2019-2030) & (K Doses)
    Figure 10. China Pneumococcal Vaccine Production (2019-2030) & (K Doses)
    Figure 11. Japan Pneumococcal Vaccine Production (2019-2030) & (K Doses)
    Figure 12. India Pneumococcal Vaccine Production (2019-2030) & (K Doses)
    Figure 13. Pneumococcal Vaccine Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Pneumococcal Vaccine Consumption (2019-2030) & (K Doses)
    Figure 16. World Pneumococcal Vaccine Consumption Market Share by Region (2019-2030)
    Figure 17. United States Pneumococcal Vaccine Consumption (2019-2030) & (K Doses)
    Figure 18. China Pneumococcal Vaccine Consumption (2019-2030) & (K Doses)
    Figure 19. Europe Pneumococcal Vaccine Consumption (2019-2030) & (K Doses)
    Figure 20. Japan Pneumococcal Vaccine Consumption (2019-2030) & (K Doses)
    Figure 21. South Korea Pneumococcal Vaccine Consumption (2019-2030) & (K Doses)
    Figure 22. ASEAN Pneumococcal Vaccine Consumption (2019-2030) & (K Doses)
    Figure 23. India Pneumococcal Vaccine Consumption (2019-2030) & (K Doses)
    Figure 24. Producer Shipments of Pneumococcal Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Pneumococcal Vaccine Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Pneumococcal Vaccine Markets in 2023
    Figure 27. United States VS China: Pneumococcal Vaccine Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Pneumococcal Vaccine Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States VS China: Pneumococcal Vaccine Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 30. United States Based Manufacturers Pneumococcal Vaccine Production Market Share 2023
    Figure 31. China Based Manufacturers Pneumococcal Vaccine Production Market Share 2023
    Figure 32. Rest of World Based Manufacturers Pneumococcal Vaccine Production Market Share 2023
    Figure 33. World Pneumococcal Vaccine Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 34. World Pneumococcal Vaccine Production Value Market Share by Type in 2023
    Figure 35. PPSV 23
    Figure 36. PCV 7/13
    Figure 37. PCV 10
    Figure 38. World Pneumococcal Vaccine Production Market Share by Type (2019-2030)
    Figure 39. World Pneumococcal Vaccine Production Value Market Share by Type (2019-2030)
    Figure 40. World Pneumococcal Vaccine Average Price by Type (2019-2030) & (USD/Dose)
    Figure 41. World Pneumococcal Vaccine Production Value by End User, (USD Million), 2019 & 2023 & 2030
    Figure 42. World Pneumococcal Vaccine Production Value Market Share by End User in 2023
    Figure 43. Child
    Figure 44. Adult
    Figure 45. World Pneumococcal Vaccine Production Market Share by End User (2019-2030)
    Figure 46. World Pneumococcal Vaccine Production Value Market Share by End User (2019-2030)
    Figure 47. World Pneumococcal Vaccine Average Price by End User (2019-2030) & (USD/Dose)
    Figure 48. Pneumococcal Vaccine Industry Chain
    Figure 49. Pneumococcal Vaccine Procurement Model
    Figure 50. Pneumococcal Vaccine Sales Model
    Figure 51. Pneumococcal Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 52. Methodology
    Figure 53. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Pfizer
GSK
MSD
Sanofipasteur
CDIBP

Related Reports

Global Pneumococcal Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Pneumococcal Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

Global Pneumococcal Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Pneumococcal Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Pneumococcal Vaccine market size was valued at USD 7408.6 million in 2023 and is forecast to a readjusted size of USD 7972.1 million by 2030 with a CAGR of 1.1% during review period.

Product Tags

Pneumococcal Vaccine

Pneumococcal Vaccine Polyvalent

23-valent Pneumococcal Vaccine

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>